Factors Modifying Outcome After MIBG Therapy in Children With Neuroblastoma—A National Retrospective Study

Factors Modifying Outcome After MIBG Therapy in Children With Neuroblastoma—A National Retrospective Study

BackgroundNeuroblastoma is the most common pediatric extracranial tumor with varied prognoses, but the survival of treated refractory or relapsing patients remains poor.ObjectiveThis analysis presents the outcomes of children with neuroblastoma undergoing MIBG therapy in Poland in 2006-2019.Study De...

Full description

Bibliographic Details
Main Authors: Marek Ussowicz, Aleksandra Wieczorek, Agnieszka Dłużniewska, Anna Pieczonka, Robert Dębski, Katarzyna Drabko, Jolanta Goździk, Walentyna Balwierz, Daria Handkiewicz-Junak, Jacek Wachowiak
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-04-01
Series:Frontiers in Oncology
Subjects:
MIBG
high-dose chemotherapy
pediatric
hematopoietic stem cell transplant
treosulfan-based conditioning
busulfan and melphalan
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.647361/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.647361/full

Similar Items